These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37288156)

  • 41. Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage.
    Singer AJ; Liu J; Yan H; Stad RK; Gandra SR; Yehoshua A
    Osteoporos Int; 2021 Dec; 32(12):2473-2484. PubMed ID: 34095966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ; Steybe D; Poxleitner P; Schmelzeisen R; Munzenmayer C; Fuellgraf H; Stricker A; Semper-Hogg W
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of pamidronate disodium for the treatment of diffuse sclerosing osteomyelitis of the mandible: A clinical study.
    Li X; Jia K; An J; Zhang Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Dec; 130(6):616-624. PubMed ID: 32771415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis.
    Yasuda Y; Iwama S; Arima H
    Endocr J; 2019 Mar; 66(3):271-275. PubMed ID: 30713246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.
    Loyson T; Van Cann T; Schöffski P; Clement PM; Bechter O; Spriet I; Coropciuc R; Politis C; Vandeweyer RO; Schoenaers J; Dumez H; Berteloot P; Neven P; Nackaerts K; Woei-A-Jin FJSH; Punie K; Wildiers H; Beuselinck B
    Acta Clin Belg; 2018 Apr; 73(2):100-109. PubMed ID: 28693379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Denosumab-associated osteonecrosis of the jaw affects osteoclast formation and differentiation: Pathological features of two cases.
    Matsushita Y; Hayashida S; Morishita K; Sakamoto H; Naruse T; Sakamoto Y; Yamada SI; Yanamoto S; Fujita S; Ikeda T; Umeda M
    Mol Clin Oncol; 2016 Feb; 4(2):191-194. PubMed ID: 26893859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.
    McKee H; Ioannidis G; Lau A; Treleaven D; Gangji A; Ribic C; Wong-Pack M; Papaioannou A; Adachi JD
    Osteoporos Int; 2020 May; 31(5):973-980. PubMed ID: 31900542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review.
    Raimondi A; Simeone N; Guzzo M; Maniezzo M; Collini P; Morosi C; Greco FG; Frezza AM; Casali PG; Stacchiotti S
    ESMO Open; 2020 Jul; 5(4):. PubMed ID: 32661185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic osteomyelitis mimicking a temporomandibular disorder: a case report of two cases.
    Takei M; Takizawa K; Ozasa K; Nishikubo S; Young A; Noma N
    Quintessence Int; 2023 Jan; 54(1):44-52. PubMed ID: 36268942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Denosumab-related osteonecrosis of the jaws: successful management with a conservative surgical approach.
    de Souza Póvoa RC; Marlierè DA; da Silveira HM; Pires FR
    Spec Care Dentist; 2016 Jul; 36(4):231-6. PubMed ID: 26859582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ).
    Fusco V; Campisi G; Bedogni A
    Support Care Cancer; 2022 Sep; 30(9):7047-7051. PubMed ID: 35312858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
    Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
    Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
    Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
    J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bisphosphonate-treatment of secondary chronic osteomyelitis of the jaw - a case report.
    Heimes D; Kämmerer PW
    J Surg Case Rep; 2023 May; 2023(5):rjad270. PubMed ID: 37251250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics.
    You Tm; Lee KH; Lee SH; Park W
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):548-53. PubMed ID: 26337218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
    Khan AA; Morrison A; Hanley DA; Felsenberg D; McCauley LK; O'Ryan F; Reid IR; Ruggiero SL; Taguchi A; Tetradis S; Watts NB; Brandi ML; Peters E; Guise T; Eastell R; Cheung AM; Morin SN; Masri B; Cooper C; Morgan SL; Obermayer-Pietsch B; Langdahl BL; Al Dabagh R; Davison KS; Kendler DL; Sándor GK; Josse RG; Bhandari M; El Rabbany M; Pierroz DD; Sulimani R; Saunders DP; Brown JP; Compston J;
    J Bone Miner Res; 2015 Jan; 30(1):3-23. PubMed ID: 25414052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis.
    Ohga N; Yamazaki Y; Tsuboi K; Kitagawa Y
    Quintessence Int; 2015; 46(7):621-6. PubMed ID: 25646168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffuse sclerosing osteomyelitis in the maxilla: case report.
    Cebeci AR; Kamburoğlu K; Oztaş B
    Dent Update; 2004 Sep; 31(7):405-6, 409. PubMed ID: 15485122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
    Body JJ; von Moos R; Niepel D; Tombal B
    BMC Urol; 2018 Sep; 18(1):81. PubMed ID: 30236112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.